Source: PR-INSIDE.COM

Press Release: Spinifex : "Spinifex Pharmaceuticals Pty Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Published

(PR-inside.com) Spinifex Pharmaceuticals Pty Ltd (Spinifex Pharma) is a biotechnology company. The company develops products for the treatment of pain. It develops EMA401 product for pain control. Spinifex Pharma's EMA401 is a AT2 receptor antagonist which is used in the treatment of chronic pain. The company conducts active medicinal chemistry program for discovery and development of selective AT2 receptor antagonists. Its products are also used to treat post therapeutic neuralgia, painful diabetic neuropathy, neuropath pain associated with HIV infection, and inflammatory pain conditions, such as rheumatoid and osteoarthritis. Spinifex Pharma is headquartered in Preston, Victoria, Australia. Spinifex Pharmaceuticals Pty Limited - Pharmaceuticals ..

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Tom McCarthy's photo - President & CEO of Spinifex Pharmaceuticals Pty. Ltd.

President & CEO

Tom McCarthy

CEO Approval Rating

66/100

Read more